Venotonics in modern clinical practice

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Chronic venous diseases (CVD) are an extremely common pathology of the circulatory system. An important component of the treatment of CVD is the use of pharmaceuticals. Their tasks include reducing the specific symptoms of the disease, enhancing the effects of other methods of treating CVD, preventing further development and complications of the disease. The main means of pharmacotherapy of CVD are called venotonics or phlebotonics. The most studied and most commonly used form of venotonics are flavonoids, which reduce the permeability of capillaries, thereby having a beneficial effect on the vessels of the microcirculatory bed. The main indications for taking venotonics are specific symptoms of CVD: a feeling of heaviness, varying degrees of discomfort, pain, itching in the lower extremities, chronic swelling and trophic skin changes. This determines the active use of venoactive drugs in the treatment of various forms of CVD. Most clinical studies show that venotonics have decongestant, anti-inflammatory, antioxidant properties, and also maintain the tone of the venous wall. The main effect of venotonics is their ability to affect the state of blood vessels both at the macrocirculatory level and at the microcirculatory level. The wide effect of venotonics confirms the effectiveness of their use in modern clinical practice in the treatment of various forms of CVD.

Full Text

Restricted Access

About the authors

А. М. Morozov

Tver State Medical University, Ministry of Health of Russia

Author for correspondence.
Email: ammorozovv@gmail.com
ORCID iD: 0000-0003-4213-5379

Candidate of Medical Sciences

Russian Federation, Tver

А. N. Sergeev

Tver State Medical University, Ministry of Health of Russia

Email: ammorozovv@gmail.com
ORCID iD: 0000-0002-9657-8063

MD

Russian Federation, Tver

E. М. Askerov

Tver State Medical University, Ministry of Health of Russia

Email: ammorozovv@gmail.com
ORCID iD: 0000-0002-2567-6088

Candidate of Medical Sciences

Russian Federation, Tver

E. U. Aslakhanova

Tver State Medical University, Ministry of Health of Russia

Email: ammorozovv@gmail.com
ORCID iD: 0000-0002-4403-7564
Russian Federation, Tver

К. R. Ispieva

Tver State Medical University, Ministry of Health of Russia

Email: ammorozovv@gmail.com
ORCID iD: 0000-0001-5376-8214
Russian Federation, Tver

Е. А. Fisyuk

Tver State Medical University, Ministry of Health of Russia

Email: ammorozovv@gmail.com
ORCID iD: 0009-0000-0582-7398
Russian Federation, Tver

P. S. Polyakov

Tver State Medical University, Ministry of Health of Russia

Email: ammorozovv@gmail.com
Russian Federation, Tver

References

  1. Кудыкин М.Н. Возможности терапии симптомов хронических заболеваний вен нижних конечностей. Амбулаторная хирургия. 2019; 1-2: 34–7 [Kudykin M.N. Possibilities of treatment of symptoms of chronic diseases of lower limbs veins. Ambulatory Surgery (Russia). 2019; 1-2: 34–7 (in Russ.)]. DOI: 10.215181995-1477-2019-1-2-34-37
  2. Черняго Т.Ю., Фомина В.С., Федык О.В. и др. Методы оценки функционального состояния эндотелия у пациентов с варикозной болезнью вен нижних конечностей: Перспективы лечебной тактики. Вестник НМХЦ им. Н.И. Пирогова. 2021; 16 (1): 145–50 [Chernyago T.Yu., Fomina V.S., Fedyk O.V. et al. Assessment methods of the functional state of the endothelium in patients with varicose veins of the lower extremities: perspectives of treatment. Bulletin of Pirogov National Medical & Surgical Center. 2021; 16 (1): 145–50 (in Russ.)]. DOI: 10.25881BPNMSC.2021.17.48.028
  3. Береговых Р., Прожерина Ю. Хронические заболевания вен – острая проблема современности. Ремедиум. 2019; 11: 27–31 [Beregovykh R., Prozherina Yu. Chronic vein diseases is a pressing issue of our time. Remedium. 2019; 11: 27–31 (in Russ.)]. DOI: 10.215181561-5936-2019-11-27-31
  4. Каторкин С.Е., Мышенцев П.Н., Лисин О.Е. и др. Сравнительная оценка клинической эффективности применения флеботоника первого поколения в комплексном лечении пациентов с хроническими заболеваниями вен нижних конечностей. Амбулаторная хирургия. 2019; 3-4: 96–103 [Katorkin S.E., Myshentsev P.N., Lisin O.E. et al. Comparative assessment of the clinical efficacy of first-generation phlebotonics in the complex treatment of patients with chronic venous diseases of the lower limbs. Ambulatory Surgery (Russia). 2019; 3-4: 96–103 (in Russ.)]. DOI: 10.215181995-1477-2019-3-4-96-103
  5. Богачев В.Ю., Болдин Б.В., Туркин П.Ю. и др. Современные показания к флеботропной терапии и ее продолжительность. Амбулаторная хирургия. 2021; 18 (1): 13–23 [Bogachev V.Yu., Boldin B.V., Turkin P.Yu. et al. Current indications for phlebotropic therapy and its duration. Ambulatory Surgery (Russia). 2021;18(1):13-23 (in Russ.)]. DOI: 10.215181995-1477-2021-18-1-13-23
  6. Davies A.H. The Seriousness of Chronic Venous Dease: A Review of Real-World Evidence. Adv Ther. 2019; 36 (1): 5–12. DOI: 10.1007s12325-019-0881-7
  7. Дунаевская С.С. Эффективность компрессионной терапии при хронической венозной недостаточности. Амбулаторная хирургия. 2020; 3-4: 13–9 [Dunaevskaya S.S. Effectiveness of compression therapy in chronic venous insufficiency. Ambulatory Surgery (Russia). 2020; 3-4: 13–9 (in Russ.)]. DOI: 10.215181995-1477-2020-3-4-13-19
  8. Кулакова А.Л. Современные методы лечения варикозной болезни нижних конечностей. Здоровье и образование в XXI веке. 2017; 19 (12): 47–51 [Kulakova A.L. Modern methods of treatment for varicose veins of lower limbs. Health and Education in the XXI century. 2017; 19 (12): 47–51 (in Russ.)]. DOI: 10.26787nydha-2226-7425-2017-19-12-47-51
  9. Дунаевская С.С. Топическая терапия при комплексном лечении хронической венозной недостаточности. Амбулаторная хирургия. 2021; 18 (2): 55–60 [Dunaevskaya S.S. Topical therapy for complex treatment of chronic venous insufficiency. Ambulatory Surgery (Russia). 2021; 18 (2): 55–60 (in Russ.)]. DOI: 10.215181995-1477-2021-18-2-55-60
  10. Гаврилов С.Г. Трансдермальные системы доставки местных средств: новые перспективы. Лечебное дело. 2021; 2: 25–32 [Gavrilov S.G. Transdermal Drug Delivery Systems: New Perspectives. Lechebnoe delo. 2021; 2: 25–32 (in Russ.)]. DOI: 10.244122071-5315-2021-12328
  11. Порембская О.Я., Косенко И.М. Фармакотерапия при хронических заболеваниях вен – как рационально выбрать флеботропный препарат? Флебология. 2018; 12 (3): 123–33 [Porembskaya O.Ya., Kosenko I.M. Pharmacotherapy of Chronic Venous Disease – how to choose Appropriate Venoactive Drug? Flebologiya. 2018; 12 (3): 123–33 (in Russ.)]. DOI: 0.17116flebo2018123123
  12. Ciumărnean L., Milaciu M.V., Runcan O. et al. The Effects of Flavonoids in Cardiovascular Diseases. Molecules. 2020; 25 (18): 4320. DOI: 10.3390molecules25184320
  13. Степанова Э.Ф., Ремезова И.П., Шевченко А.М. и др. Флебопротекторы на базе флавоноидов: лекарственные формы, биофармацевтическая характеристика, технологические особенности. Фармация и фармакология. 2020; 8 (6): 405–15 [Stepanova E.F., Remezova I.P., Shevchenko A.M. et al. Phleboprotectors based on flavonoids: dosage forms, biopharmaceutical characteristics, technological features. Pharmacy & Pharmacology. 2020; 8 (6): 405–15 (in Russ.)]. DOI: 10.191632307-9266-2020-8-6-405-415
  14. Мамчур В.И., Опрышко В.И., Носивец Д.С. Клинико-фармакологические аспекты рациональной фармакотерапии хронической венозной недостаточности. Хирургия. Восточная Европа. 2021; 10 (1): 109–16 [Mamchur V., Opryshko V., Nosivets D. Clinical and pharmacological aspects of rational pharmacotherapy of chronic venous insufficiency. Surgery. East Europe. 2021; 10 (1): 109–16 (in Russ.)]. DOI: 10.34883PI.2021.10.1.019
  15. Дженина О.В., Лобанов В.Н., Гордеев В.С. Фармакотерапия хронической венозной недостаточности нижних конечностей. Амбулаторная хирургия. 2018; 1-2: 26–31 [Dzhenina O.V., Lobanov V.N., Gordeev B.S. Pharmacotherapy of chronic venous insufficiency of the lower extremities. Ambulatory Surgery (Russia). 2018; 1-2: 26–31 (in Russ.)]. DOI: 10.215181995-1477-2018-1-2-26-31
  16. Cazaubon M., Benigni J.P., Steinbruch M. et al. In There a Difference in the Clinical Efficacy of Diosmin and Micronized Purified Flavonoid Fraction for the Treatment of Chronic Venous Dorders? Review of Available Evidence. Vasc Health and Risk Manag. 2021; 16 (17): 591–600. DOI: 10.2147VHRM.S324112
  17. Khryshchanovich V.Y., Nebylitsin Y.S., Kosinets V.A. Efficacy of Micronized Purified Flavonoid Fraction-Based Venoactive Therapy After Endovenous Mechanochemical Obliteration: Prospective Comparative Study. Drugs Real World Outcomes. 2021; 8 (3): 349–58. DOI: 10.1007s40801-021-00249-4
  18. Талибов О.Б. Фармакология препаратов, применяющихся при хронических заболеваниях вен. Хирургия. Журнал им. Н.И. Пирогова. 2019; 2: 106–9 [Talibov OB. Pharmacology of the drugs prescribed for chronic venous diseases. Pirogov Russian Journal of Surgery. 2019; 2: 106–9 (in Russ.)]. DOI: 10.17116hirurgia2019021106
  19. Mansilha A., Sousa J. Benefits of venoactive drug therapy in surgical or endovenous treatment for varicose veins: A systematic review. Int Angiol. 2019; 38 (4): 291–8. DOI: 10.23736S0392-9590.19.04216-0
  20. Bouskela E., Lugli M., Nicolaides A. New Perspectives on Microned Purified Flavonoid Fraction in Chronic Venous Dease: From Microvalves to Clinical Effectiveness. Adv Ther. 2022; 39: 4413–22. DOI: 10.1007s12325-022-02218-x
  21. Mansilha A., Sousa J. Pathophysiological Mechanms of Chronic Venous Dease and Implications for Venoactive Drug Therapy. Int J Mol Sci. 2018; 19 (6): 1669. DOI: 10.3390ijms19061669
  22. Dias M.C., Pinto D.C.G.A., Silva A.M.S. Plant Flavonoids: Chemical Characteristics and Biological Activity. Molecules. 2021; 26 (17): 5377. DOI: 10.3390 molecules26175377
  23. Mansilha A., Gianesini S., Ulloa J.H. et al. Pharmacological treatment for chronic venous disease: an umbrella review of systematic reviews. Int Angiol. 2022; 4 1(3): 249–57. DOI: 10.23736S0392-9590.22.04877-5
  24. Nicolaides A., Kakkos S., Baekgaard N. et al. Management of chronic venous dorders of the limbs. Guidelines According to Scientific Evidence. Part I. Int Angiol. 2018; 37 (3): 181–254. DOI: 10.23736S0392-9590.18.03999-8
  25. Zagriadskii E.A., Bogomazov A.M., Golovko E.B. Conservative Treatment of Hemorrhoids: Results of an Observational Multicenter Study. Adv Ther. 2018; 35 (11): 1979–92. DOI: 10.1007s12325-018-0794-x
  26. Raffetto J.D., Khalil R.A. Mechanisms of Lower Extremity Vein Dysfunction in Chronic Venous Disease and Implications in Management of Varicose Veins. Vessel Plus. 2021; 5: 36. DOI: 10.205172574-1209.2021.16
  27. Odai T., Terauchi M., Kato K. et al. Effects of Grape Seed Proanthocyanidin Extract on Vascular Endothelial Function in Participants with Prehypertension: A Randomized, Double-Blind, Placebo-Controlled Study. Nutrients. 2019; 11 (12): 2844. DOI: 10.3390nu11122844
  28. Богачев В.Ю., Мансилья А., Болдин Б.В. и др. Патогенетическое обоснование флеботропной терапии хронических заболеваний вен. Стационарозамещающие технологии. Амбулаторная хирургия. 2019; 3-4: 19–33 [Bogachev V.Yu., Mansilla A., Boldin B.V., Rodionov S.V., Dzhenina O.V. Pathogenetic substantiation of phlebotropic therapy for chronic venous diseases. Нospital-replacing technologies: Ambulatory surgery. 2019; 3-4: 19–33 (in Russ.)]. Отозвана/Retracted 21.03.2022. DOI: 10.215181995-1477-2019-3-4-19-33
  29. Богачев В.Ю., Родионов С.В., Дженина О.В. Фармакотерапия хронических заболеваний вен. Новые европейские рекомендации. Амбулаторная хирургия. 2018; 3-4: 12–21 [Bogachev V.Yu., Rodionov S.V., Dzhenina O.V. Pharmacotherapy of chronic vein diseases. New European guidelines. Ambulatory Surgery (Russia). 2018; 3-4: 12–21 (in Russ.)]. DOI: 10.215181995-1477-2018-3-4-12-21
  30. Idris S., Mishra A., Khushtar M. Phytochemical, ethanomedicinal and pharmacological applications of escin from Aesculus hippocastanum L. towards future medicine. J Basic Clin Physiol Pharmacol. 2020; 31 (5). DOI: 10.1515jbcpp-2019-0115
  31. Gallelli L. Escin: a review of its anti-edematous, anti-inflammatory, and venotonic properties. Drug Des Devel Ther. 2019; 13: 3425–37. DOI: 10.2147DDDT.S207720
  32. Богачев В.Ю., Болдин Б.В., Туркин П.Ю. Экстракт конского каштана. Update 2022. Consilium Medicum. 2022; 24 (1): 42–8 [Bogachev V.Y., Boldin B.V., Turkin P.Y. Horse Chestnut Extract. Update-2022. Consilium Medicum. 2022; 24 (1): 42–8 (in Russ.)]. DOI: 10.2644220751753.2022.1.201439
  33. Черных К.П., Кубачев К.Г., Семенов А.Ю. и др. Современные методы консервативного и хирургического лечения пациентов с варикозной болезнью нижних конечностей. Кардиология и сердечно-сосудистая хирургия. 2019; 12 (3): 235–40 [Chernykh K.P., Kubachev K.G., Semenov A.Yu. et al. Modern methods of conservative and surgical treatment of patients with lower limb varicose vein disease (in Russian only). Kardiologiya i Serdechno-Sosudistaya Khirurgiya. 2019; 12 (3): 235–40 (in Russ.)]. DOI: 10.17116kardio201912031235
  34. Воронков А.В., Гамзелева О.Ю. Обзор современных флеботропных препаратов на основе флавоноидов как перспективных эндотелиопротекторов при лечении хронических заболеваний вен. Амбулаторная хирургия. 2019; 1-2: 27–33 [Voronkov A.V., Gamzeleva O.Yu. Review of modern phlebotrophic preparations based on flavonoids as perspective endothelioprotectors in the treatment of chronic diseases of the veins. Ambulatory Surgery (Russia). 2019; 1-2: 27–33 (in Russ.)]. DOI: 10.215181995-1477-2019-1-2-27-33
  35. Богачев В.Ю., Болдин Б.В., Родионов С.В. и др. Кальция добезилат – идеальный незнакомец. Стационарозамещающие технологии: Амбулаторная хирургия. 2020; 1-2: 15–21 [Bogachev V.Yu., Boldin B.V., Rodionov S.V. et al. Calcium dobesilate – a perfect stranger. Hospital-replacing Technologies: Outpatient surgery. 2020; 1-2: 15–21 (in Russ.)]. DOI: 10.215181995-1477-2020-1-2-15-21
  36. Sheikh P., Lohsiriwat V., Shelygin Y. Micronized Purified Flavonoid Fraction in Hemorrhoid Disease: A Systematic Review and Meta-Analysis. Adv Ther. 2020; 37 (6): 2792–812. DOI: 10.1007s12325-020-01353-7
  37. Трухан Д.И., Деговцов Е.Н., Белкина Л.В. Консервативное лечение геморроя: в фокусе комбинация трибенозида и лидокаина. Амбулаторная хирургия. 2019; 1-2: 106–111 [Trukhan D.I., Degovtsov E.N., Belkina L.V. Conservative treatment of hemorrhoids: focus on combination tribenoside and Lidocaine. Ambulatory Surgery (Russia). 2019; 1-2: 106–11 (in Russ.)]. DOI: 10.215181995-1477-2019-1-2-106-111
  38. Российские клинические рекомендации по диагностике и лечению хронических заболеваний вен. Флебология. 2018; 12 (3): 146–240 [Russian Clinical Guidelines for the Diagnostics and Treatment of Chronic Venous Diseases. Flebologiya. 2018; 12 (3): 146–240 (in Russ.)]. DOI: 10.17116flebo20187031146
  39. Гаврилов С.Г., Москаленко Е.П., Каралкин А.В. Эффективность и безопасность применения микронизированной очищенной фракции флавоноидов в лечении сочетанной варикозной болезни таза и нижних конечностей. Флебология. 2018; 12 (3): 109–17 [Gavrilov S.G., Moskalenko E.P., Karalkin A.V. The Effectiveness and Safety of the Application of the Microionized Purified Flavonoid Fraction for the Treatment of the Patients Presenting with Concomitant Varicose Veins of the Pelvis and Lower Extremities. Flebologiya. 2018; 12 (3): 109–17 (in Russ.)]. DOI: 10.17116flebo2018123109
  40. Bogachev V., Boldin B., Turkin P. et al. Micronized purified flavonoid fraction-based conservative treatment of chronic venous disease in a real-world setting. Future Cardiol. 2022; 18 (10): 777–85. DOI: 10.2217fca-2022-0026
  41. Морозов А.М., Сергеев А.Н., Аскеров Э.М. и др. Оценка распространенности и факторов риска варикозного расширения вен. Вестник медицинского института "РЕАВИЗ": реабилитация, врач и здоровье. 2020; 6: 66–72 [Morozov A.M., Sergeev A.N., Askerov E.M. et al. Assessment of prevalence and risk factors of varicosis. Bulletin of the Medical Institute "REAVIZ" (Rehabilitation, Doctor and Health). 2020; 6: 66–72 (in Russ.)]. doi: 10.20340/vmi-rvz.2020.6.8
  42. Стойко Ю.М., Цыплящук А.В., Крыжановский С.М. и др. Терапия диосмином при хронических заболеваниях вен в условиях амбулаторной практики: результаты неинтервенционного исследования СТАТУС. Флебология. 2020; 14 (3): 230–6 [Stoyko Yu.M., Tsyplyashchuk A.V., Kryzhanovskiy S.M. et al. Diosmin therapy for chronic vein diseases in outpatient settings: results of non-intervention STATUS study. Flebologiya. 2020; 14 (3): 230–6 (in Russ.)]. DOI: 10.17116flebo202014031230

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies